Publication

Peer-Reviewed

Evidence-Based Oncology

January 2021
Volume27
Issue 1

Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Supplemental materials for article examining the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.

Related Videos
Jade E. Jones, MD
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health
Sarah Anderson, oncology strategy lead director, Novotech
Sarah Anderson, oncology strategy lead director, Novotech
Dawn Klemow, MD, assistant clinical professor, The University of Texas Southwestern Medical Center
Mikael Eriksson, PhD.
Roberto Salgado, MD.
Komal Jhaveri, MD, FACP.
Mei Wei, MD.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo